Stockreport

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

Koninklijke Philips N.V. NY Registry Shares  (PHG) 
US:NYSE Investor Relations: philips.com/a-w/about/investor.html
PDF April 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam [Read more]